This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Sep 15;353(11):1135-46.

doi: 10.1056/NEJMra050436.

Beta-thalassemia

Deborah Rund¹, Eliezer Rachmilewitz

Affiliations

PMID: 16162884
DOI: 10.1056/NEJMra050436

Review

Beta-thalassemia

Deborah Rund et al. N Engl J Med. 2005.

. 2005 Sep 15;353(11):1135-46.

doi: 10.1056/NEJMra050436.

Authors

Deborah Rund¹, Eliezer Rachmilewitz

Affiliation

¹ Hematology Department, Hebrew University-Hadassah Medical Center, Ein Kerem, Jerusalem, Israel. rund@cc.huji.ac.il

PMID: 16162884
DOI: 10.1056/NEJMra050436

No abstract available

PubMed Disclaimer

Similar articles

Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion.
Kattamis A, Kassou C, Berdousi H, Ladis V, Papassotiriou I, Kattamis C. Kattamis A, et al. Haematologica. 2003 Dec;88(12):1423-5. Haematologica. 2003. PMID: 14687998 Clinical Trial. No abstract available.
Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
Balocco M, Carrara P, Pinto V, Forni GL. Balocco M, et al. Am J Hematol. 2010 Jun;85(6):460-1. doi: 10.1002/ajh.21711. Am J Hematol. 2010. PMID: 20513129 No abstract available.
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience.
Efthimia V, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, Perifanis V. Efthimia V, et al. Ann Hematol. 2013 Jan;92(2):263-5. doi: 10.1007/s00277-012-1558-3. Epub 2012 Aug 30. Ann Hematol. 2013. PMID: 22933235 No abstract available.
Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.
Marsella M, Borgna-Pignatti C. Marsella M, et al. Hematol Oncol Clin North Am. 2014 Aug;28(4):703-27, vi. doi: 10.1016/j.hoc.2014.04.004. Hematol Oncol Clin North Am. 2014. PMID: 25064709 Review.
Retinal abnormalities in β-thalassemia major.
Bhoiwala DL, Dunaief JL. Bhoiwala DL, et al. Surv Ophthalmol. 2016 Jan-Feb;61(1):33-50. doi: 10.1016/j.survophthal.2015.08.005. Epub 2015 Aug 29. Surv Ophthalmol. 2016. PMID: 26325202 Free PMC article. Review.

See all similar articles

Cited by

A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province.
Xia Y, Huang C, Yang M, Zhang M, Lu Y. Xia Y, et al. Front Genet. 2024 Nov 7;15:1422462. doi: 10.3389/fgene.2024.1422462. eCollection 2024. Front Genet. 2024. PMID: 39574796 Free PMC article.
Assessment of diagnostic accuracy of Gazelle: A point-of-care testing device for screening β-thalassemia trait.
Singh N, Seth T, Dass J. Singh N, et al. Indian J Med Res. 2024 Aug;160(2):194-200. doi: 10.25259/ijmr_1986_23. Indian J Med Res. 2024. PMID: 39513207 Free PMC article. Review.
The clinical anti-inflammatory effects and underlying mechanisms of silymarin.
Zhao Y, Zhou Y, Gong T, Liu Z, Yang W, Xiong Y, Xiao D, Cifuentes A, Ibáñez E, Lu W. Zhao Y, et al. iScience. 2024 Oct 9;27(11):111109. doi: 10.1016/j.isci.2024.111109. eCollection 2024 Nov 15. iScience. 2024. PMID: 39507256 Free PMC article. Review.
Gene Therapy: A Revolutionary Step in Treating Thalassemia.
Malay J, Salama RAA, Alam Qureshi GS, Ammar ARAA, Janardhan G, Safdar M, Elshamy HAH. Malay J, et al. Hematol Rep. 2024 Oct 21;16(4):656-668. doi: 10.3390/hematolrep16040064. Hematol Rep. 2024. PMID: 39449307 Free PMC article. Review.
β-Thalassemia Major Complicated by Acute Myeloid Leukemia.
Khalid M, Suhail M, Faisal A, Poombal F. Khalid M, et al. Cureus. 2024 Sep 16;16(9):e69557. doi: 10.7759/cureus.69557. eCollection 2024 Sep. Cureus. 2024. PMID: 39421114 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information